{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for azithromycin in Related Substance Name (approximate match)
N’-(desmethyl)azithromycin (CP-64434 hydrate) is the metabolite of azithromycin. Azithromycin is an effective therapeutic agent for oral treatment of sexually transmitted diseases, upper and lower respiratory tract infections, and skin and skin structure infections. 0.1 and 7.6% of azithromycin dose are excreted as N’-(desmethyl)azithromycin during a day in urine and feces, respectively. 2.9% of dose - biliary excretion.
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Azaerythromycin A is a novel intermediate of Azithromycin which acts as an antibiotic. Azithromycin binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA.
Status:
Possibly Marketed Outside US
Source:
Pro-Collagen Marine Moisture Essence by Acheson & Acheson Ltd.
(2021)
Source URL:
First approved in 2000
Source:
NDA022434
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Conditions:
LBA (4-O-beta-D-galactopyranosyl-D-gluconic acid) is an aldonic acid obtained from the oxidation of lactose, with high potential applications as an ingredient in foods and pharmaceutical products, because of its antioxidant, chelating
and humectant properties.
Status:
US Approved Rx
(2013)
First approved in 1958
Class:
MIXTURE
